Indomethacin inhibits kidney metastasis in Bomirski melanoma-bearing hamsters, and modulates natural killer cytotoxic activity of tumor hosts in vivo and in vitro

Anticancer Research

Volumn 18, Issue 5 A, 1998, Pages 3549-3554

  Bigda, Jacek ^a   Mysliwski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Cytokines; Indomethacin; Melanoma; Metastasis; NK cells

Indexed keywords

INDOMETACIN; INTERLEUKIN 2; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXICITY; HAMSTER; IMMUNOMODULATION; KIDNEY METASTASIS; MELANOMA; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; CRICETINAE; CYCLOOXYGENASE INHIBITORS; HUMANS; INDOMETHACIN; INTERLEUKIN-2; KIDNEY NEOPLASMS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MELANOMA, AMELANOTIC; MELANOMA, EXPERIMENTAL; MESOCRICETUS; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031760514     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Takasugi M, Ramseyer A, Takasugi J: Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression. Cancer Res 37: 413-418, 1977.
2. Hanna N: The role of natural killer cells in the control of tumor growth and metastasis. Biochim Biophys Acta 780: 213-226, 1985.
3. Pross H P, Lotzova E: Role of natural killer cells in cancer. Nat Immun 12: 279-292, 1993.
4. Naume B, Espevik T: Immunoregulatory effects of cytokines on natural killer cells. Scand J Immunol 40: 128-134, 1994.
5. Bomirski A, Slominski A, Bigda J: The natural history of the family of transplantable melanomas in hamsters. Cancer Metastasis Rev 7: 95-118, 1988.
6. Slominski A, Paus R: Bomirski melanomas: A versatile and powerful model for pigment cell and melanoma research. Int J Oncol 2: 221-228, 1993.
7. Bigda J, Mysliwski A, Mysliwska J, Witkowski J, Kmiec Z, Bomirski A: Natural killer sensitivity of four Bomirski melanoma variants. Cancer Lett 44: 67-72, 1989.
8. Bigda J, Mysliwski A, Sosnowska D, Romanowski P, Bomirski A: Natural killer sensitivity of tumor cells isolated from primary and metastatic lesions of four Bomirski melanoma variants. Clin Exp Metastasis 9: 57-65, 1991.
9. Mysliwski A, Bigda J, Mysliwska J, Witkowski J, Sosnowska D: Changes of natural killer cytotoxic activity and natural killer sensitivity during growth of Bomirski melanotic (Ma) and amelanotic (Ab) melanomas. Neoplasma 42: 15-19, 1995.
10. Brunda MJ, Herberman RB, Holden HT: Inhibition of murine natural killer cell activity by prostaglandins. J lmmunol 124: 2682-2687, 1980.
11. Lala PK, Parhar RS, Singh P: Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis. Cell Immunol 99: 108-118, 1986.
12. Ibayashi Y, Hoon DSB, Golub SH: The regulatory effect of adherent cells on lymphokine activated killer cells. Cell Immunol 110: 365-378, 1987.
13. Lala P K, Parhar R S: Cure of B16F10 melanoma lung metastasis in mice by chronic indomethacin therapy combined with repeated rounds of interleukin 2: characteristics of killer cells generated in situ. Cancer Res 48: 1072-1079, 1988.
14. Kuppen PJK, Eggermont AMM, Marinelli A, de Heer E, van de Velde CJH, Fleuren G J: Induction of lymphokine-activated killer activity in rat splenocyte cultures: the importance of 2-mercaptoethanol and indomethacin. Cancer Immunol Immunother 33: 28-32, 1991.
15. Lala PK, Parhar RS: Eradication of spontaneous and experimental adenocarcinoma metastases with chronic indomethacin and intermittent IL-2 therapy. Int J Cancer 54: 677-684, 1993.
16. Lotze MT, Custer MC, Bolton ES, Wiebke EA, Kawakami Y, Rosenberg SA: Mechanisms of Immunologic antitumor therapy: Lessons from the laboratory and clinical applications. Hum Immunol 28: 198-207, 1990.
17. Yagita M, Grimm E A: Current understanding of the lymphokine-activated killer cell phenomenon. Prog Exp Tumor Res 32: 213-226. Ed. Homburger F, S Karger, Basel, 1988.
18. Reich R, Martin G R: Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells. Prostaglandins 51: 1-17, 1996.
19. Tsujii M, Kawano S, DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 95: 3336-3340, 1997.
20. Mysliwski A, Sosnowska D, Bigda J: Effect of tumor excision on NK cytotoxic activity and formation of metastases of Bomirski melanoma in hamsters. Neoplasma 43: 311-313, 1996.